NORTH AMERICA AUTOIMMUNE MARKET 2014 - 2019 Market Shares, Forecasts & Trends
mordorintelligence.com
REPORT DESCRIPTION North America autoimmune disease diagnostics market is estimated to reach $0.4 billion in 2018 from $284 million in 2012 with a CAGR 5.87%. U.S being the largest market for autoimmune treatments holds 43% share in the global market, it will sustain its position and will hold 44% market share in 2016. Autoimmune diseases are a group of diseases characterized by inflammatory reactions caused by immune responses mistakenly generated against body tissues. A boost is expected for the U.S. autoimmune disease diagnostic testing market in 2014 due to the implementation of the Patient Protection and Affordable Care Act (PPACA) Growing public awareness for autoimmune diseases, Expansion in coverage allowed by Patient protection and affordable care act, Improved laboratory automation are the key driving factors for the market. Furthermore, Increased partnerships with Physicians and Clinical Laboratories also fuels the market growth. While, Slow turnaround time for autoimmune disease diagnostic test results, high frequency of false positive results, relatively low percentage of localized autoimmune diseases are the constraints for the market growth. North America autoimmune disease diagnostic market is segmented based on types i. e Localized autoimmune disease diagnostic and Systemic Autoimmune disease diagnostic segment, based on products( Drugs, Therapeutic and monitoring equipments, Diagnostic equipments), based on Service market( Consultation and Diagnosis, Therapy & Monitoring, Drug development and discovery), based on Technology( Bridge therapy, DMARD, Topical therapy, Phototherapy, Helminthic Therapy, Recombinant technology). Major market players for the market are Roche, Abbott autoimmune, Biogen Idec, Eli Lilly, Glaxosmithkline.
What makes our report unique? 1. A wide and in-depth analysis of market trends and future forecasts, describes market drivers, constraints, and opportunities of autoimmune market. 2. We provide the longest possible market segmentation based on products, services, applications, technology. 3. This US Autommuine disease diagnostic report gives a bird’s eye-view of the market competitive landscape which includes mergers & acquisitions, Collaborations., new product launches and key players in the market.
SAMPLE FIGURES Global Market Size (USD Million)
2012
2013
2014
2015
2016
2017
2018
North America Market Size (USD Million)
2012
2013
2014
2015
2016
2017
2018
TABLE OF CONTENTS 1.Introduction 2.Executive Summary 3.Market Overview 3.1 North America Autoimmune Disease Diagnostic Market 3.2 Trends and Forecast 3.3 Market Size and Share Estimation 3.4 Key Products and Services in Market 3.5 Technologies In North America Autoimmune disease diagnostic market 4.Market Dynamics 4.1 Market Drivers 4.1.1 Growing Public awareness of autoimmune disease 4.1.2 Expansion in Coverage Allowed by Patient Protection and Affordable Care Act 4.1.3 Improved Laboratory Automation 4.1.4 Partnerships with Physicians and Clinical Laboratories 4.2 Market Restraints 4.2.1 Slow turnaround Time for Autoimmune Disease Diagnostic Test Results 4.2.2 High Frequency of False Positive Results 4.2.3 Lacking Automation and Shortage of Skilled Technicians 4.2.4 Relatively low prevalence of Localized Autoimmune Diseases. 5. North America Autoimmune Disease Market Diagnosis 5.1 Identification of human autoantibodies 5.2 Techniques and methods used for the detection of antibodies
5.2.1 Immunofluorescence 5.2.2 Enzyme immunoassay 5.2.3 Multiplexed immunoassays 5.2.4 Microarray based assays 5.2.5 Bead-based assay 5.2.6 Proteomic’s technologies for the study and diagnosis of autoimmune diseases
6.MARKET SEGMENTATION 6.1 North America Autoimmune Disease Market Diagnosis Segmentation, By Types 6.1.1 Localized Autoimmune Disease Diagnostics Segment 6.1.1.1 Forecasts and Trends 6.1.1.2 Market Share and Competitive Analysis 6.1.1.3 Multiple Sclerosis 6.1.1.4 Inflammatory Bowel Disease 6.1.1.5 Type I Diabetes 6.1.1.6 Thyroid 6.1.2 Systemic Autoimmune Disease Diagnostics Segment 6.1.2.1 Forecasts and Trends 6.1.2.2 Market Share and Competitive Analysis 6.1.2.3 Rheumatoid Arthritis 6.1.2.4 Psoriasis 6.1.2.5 Lupus 6.2 North America Autoimmune Disease Market Diagnosis Segmentation, By Products
6.2.1 Drugs 6.2.2 Therapeutic and Monitoring Equipments 6.2.3 Diagnostic Equipments 6.3 North America Autoimmune Disease Market Diagnosis Segmentation, By Service Market 6.3.1 Consultation & Diagnosis 6.3.2 Therapy & Monitoring 6.3.3 Drug Development and Discovery
6.4 North America Autoimmune Disease Market Diagnosis Segmentation, By Technology
6.4.1 DMARD (disease-modifying anti-rheumatic drugs) and biologic DMARD therapy 6.4.2 Bridge therapy 6.4.3 Topical therapy 6.4.4 Phototherapy 6.4.5 Helminthic therapy 6.4.6 Fecalbacteriotherapy 6.4.7 Haematopoietic stem-cell transplantation 6.4.8 Recombinant technology
6.5 North America Autoimmune Disease Market Diagnosis Segmentation, By Geography 6.5.1 North America
6.5.1.1 US 6.5.1.2 Canada 6.5.1.3 Mexico
7. Competitive Landscape 7.1 New Product Launch 7.2 Market Share Analysis by Key Players 7.3 Mergers & Acquisitions 8. Company profiles Roche Abbott Autoimmune Inc. Bayer-Schering Pharmaceuticals Biogen Idec Eli Lilly GlaxosmithKline
!
Mordor Intelligence LLP No. 30, Padma Nilaya, Chola Nagar Bangalore, Karnataka, India 560032 +1 781 881 1110 | info@mordorintelligence.com
Copyright Š 2014 Mordor Intelligence LLP All Rights Reserved. This document contains highly confidential information and is the sole property of Mordor Intelligence LLP. No part of it may be circulated, copied, quoted, or otherwise reproduced without the approval of Mordor Intelligence LLP.
7 | Mordor Intelligence
!